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A BREAKTHROUGH IN 
TAMOXIFEN THERAPY 
Ki 
The Symphony," the 
newest MRI platform for 
cardiovascular imaging, 
was recently installe 
the Institute's research 
facilities in the East 
Building on Scott Avenue. 
The scanner is manufac- 
tured by Siemens Medical 
Systems, Inc. and will 
play an important role 
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MALLINCKRODT INSTITUTE OF RADIOLOGY 
VERTEBROPLASTY: MIR MAKES PROGRESS IN TREATING 
BONE PAIN 
Musculoskeletal radiologists at Mallinckrodt Insti- 
tute are perfecting a procedure that has the poten- 
tial to provide pain relief and mobility for patients 
who suffer from the debilitative effects of spinal 
bone loss and vertebral compression fractures. 
BREAKTHROUGH IN TAMOXIFEN THERAPY 
Using the anticancer agent tamoxifen and a non- 
invasive radiology technology called positron 
emission tomography, researchers can predict— 
within two weeks of initiation of treatment—the 
effectiveness of tamoxifen therapy in patients with 
metastatic breast cancer. 
PROTON BEAMS, A NEW APPROACH TO CANCER 
THERAPY 
An MIR radiation oncology resident discusses a 
special, proton-based form of cancer treatment 
and shares his experiences during a two-month fel- 
lowship at the only clinical proton therapy facility 
in the United States. 
SOLVERS AND PLANNERS 
In the mid-1970s Mallinckrodt Institute was among 
the first radiology departments worldwide to 
develop and to install information systems. Now 
some 20 years later, the MIR Computer Facilities 
group is efficiently supporting more than 1,000 
MIR and BJC users while planning for the chal- 
lenges of the radiology department of the future. 
SPOT NEWS 
FYI 
ON THE COVER: 
Breast cancer cells response to estrogen can determine the type of treatment 
used to combat breast cancer. In this positron emission tomography image, the 
increased uptake of an imaging agent called fluoroestradiol indicates that this 
breast cancer (shown in upper left quadrant of image) is estrogen receptor pos- 







Marcus Raichle, MD, 
codirector of the Division of 
Radiological Sciences, and 
Michael Posner, PhD, a for- 
mer Washington University 
School of Medicine faculty 
member, received the Amer- 
ican Philosophical Society's 
1998 Karl Spencer Lashley 
Award in recognition of 
their contributions to brain 
imaging. The award was 
presented in November in 
Philadelphia and honors 
Karl Spencer Lashley, an 
American psychologist who 
studied the relation between 
brain mass and learning 
ability. 
Raichle and Posner 
began their successful col- 
laborative research at Wash- 
ington University in 1985. In 
1996, their study of neu- 
roimaging and understand- 
ing the cognitive process in 
the human brain earned the 
11th Annual Charles A. Dana 
Award for Pioneering 
Achievements in Health and 
Education. Posner, a psy- 
chology professor, is now on 
faculty at the University of 
Oregon; Raichle is a profes- 
sor of radiology and of neu- 
rology and neurobiology. 
Founded in 1743 by 
Benjamin Franklin, the 
American Philosophical 
Society (APS) is the oldest 
learned society in the United 
States. Its original members 
were the "most ingenious 
and curious men who would 
promote useful knowledge in 
the colonies." The APS has 
evolved into an international 
institution of more than 700 
distinguished scientists and 
scholars from the fields of 
mathematical and physical 
sciences, biological sciences, 
social sciences, humanities, 
and arts and public affairs. 
Visit Web site 
www. imaging, wustl. edu/ 
meetings/ for more informa- 
tion about the three interna- 
tional radiopharmaceutical 
symposia scheduled this 
summer at the Washington 
University Medical Center. 
Information also is available 
by e-mailing ISRC13@ 
mirlink.wustl.edu or by 
calling the office of Dr. 
Michael Welch, symposia 




In September, the 
International Skeletal Soci- 
ety (ISS) presented its silver 
medal to Louis Gilula, MD, 
chief of MIR's muscu- 
loskeletal radiology, in 
recognition of his active 
support of the society's 
interdisciplinary study of 
the pathogenesis, diagnosis, 
and treatment of skeletal 
disease. Since the society's 
inception in 1983, Gilula has 
been a leader of key ISS 
committees, including the 
Refresher Course Program, 
the Ad Hoc Committee on 
Refresher Course Planning, 
the Ad Hoc Liaison-Future 
Planning Committee, and 
the Committee for Fellow- 
ship Accreditation of Mus- 
culoskeletal Radiology. 
An important segment 
of Gilula's research is diag- 
nosing and treating the myr- 
iad causes of chronic wrist 
pain, a challenge for radiolo- 
gists and surgeons due to 
the wrist's complex struc- 
ture. Under Gilula's leader- 
ship a clinical center for 
patients with wrist pain has 
been developed at the Insti- 
tute, with referrals from 
hand surgeons throughout 
the metropolitan St. Louis 
area and the bistate region. 
Gilula is a fellow of the 
American College of Radiol- 
ogy and an honorary mem- 
ber of the American Society 
for Surgery of the Hand. He 
is on the review board and 
editorial staff of several 
leading scientific journals, 
including Radiology, the 
American Journal of 
Roentgenology, Skeletal 
Radiology, and the Ameri- 
can Journal of Orthopedics. 
He is a founding member 
of the American Society for 
Musculoskeletal Radiology 
and a co-organizer since 
1987 of the International 
Wrist Investigator's 
Workshop. 
After receiving a med- 
ical degree from the Univer- 
sity of Illinois School of 
Medicine, Gilula completed 
a one-year internship at San 
Francisco General Hospital. 
He completed a two-year 
radiology training program 
at DeWitt Army Hospital and 
three years of radiology resi- 
dency at St. Louis City Hos- 
pital. Gilula joined the 
faculty of Mallinckrodt 
Institute in 1973 as an 
instructor in radiology and 
was appointed professor of 
radiology in 1982. He also 
holds joint appointments at 
professor of plastic and 
reconstructive surgery and 
of orthopaedic surgery. 
MALLINCKRODT INSTITUTE OF RADIOLCX      >       ™G 
Evens heads 
ACR 
Director of Mallinckrodt 
institute Ronald Evens was 
installed in September as 
president of the American 
College of Radiology (ACR). 
With more than 31,000 mem- 
bers, the ACR is the major 
radiological association in the 
nation. Prior to being named 
president, Evens was chair- 
man of the ACR's Board of 
Chancellors, the governing 
body responsible for deter- 
mining policy standards. 
During Evens' 27 years of 
leadership, Mallinckrodt Insti- 
tute underwent a major 
expansion program and is 
now one of the largest acade- 
mic radiology departments 
nationwide, with responsibil- 
ity for more than 500,000 radi- 
ologic examinations per year. 
A diagnostic radiologist, 
Evens is the Elizabeth 
Mallinckrodt professor of 
radiology and head of the 
Department of Radiology. He 
> served as past president 
and chief executive officer of 
St. Louis Children's Hospital, 
past vice-chancellor of finan- 
cial affairs at Washington Uni- 
versity, past vice president of 
the Washington University 
Medical Center Board of 
Directors, and past president 
of the Association of Univer- 
sity Radiologists (AUR) and of 
the American Roentgen Ray 
Society (ARRS). 
In 1990, he was 
appointed to the editorial 
board of the Journal of the 
American Medical Associa- 
tion, considered one of the 
premier medical and scientific 
journals worldwide. Evens 
received the prestigious Gold 
Medal awards of the AUR and 
the ARRS in 1996 and 1997, 
respectively, for his outstand- 
ing contributions to the spe- 
cialty of radiology. 
THORACIC 
MAGING 




Richard Slone, MD, 
assistant professor of radiol- 
ogy; Fernando Gutierrez, 
MD, associate professor of 
radiology; and Andrew 
Fisher, MD, assistant profes- 
sor of radiology, are editors 
of Thoracic Imaging: A 
Practical Approach.   Pub- 
lished by McGraw-Hill, this 
concise review provides 
vital information for diag- 
nosing and managing 
patients with chest disease. 
Chapters devoted to a single 
topic or disease, along with 
hundreds of detailed images 
and drawings, provide an 
invaluable guide for physi- 
cians. Slone, Gutierrez, and 
Fisher authored several 
chapters as did Washington 
University School of Medi- 
cine doctors Bryan Meyers 
and Roger Yusen and former 
MIR fellows Matthew Fleish- 
man and Robert Kanterman. 
Slone and Fisher also 
edited Pocket Guide to Body 
CT Differential Diagnosis. 
Organized by body region, 
the Pocket Guide provides 
quick access to clinical find- 
ings, diagnostic considera- 
tions, and aids for the 
accurate interpretation of 
CT scans. Contributing 
authors are doctors Dennis 
Balfe, professor of radiol- 
ogy; Fleishman; David Gier- 
ada, assistant professor of 
radiology; Louis Gilula, pro- 
fessor of radiology, of plas- 
tic and reconstructive 
surgery, and of orthopaedic 
surgery; Christopher Gor- 
don, instructor in radiology; 
Gutierrez; Cary Siegel, assis- 
tant professor of radiology; 
and Franz Wippold, associ- 
ate professor of radiology. 
RSNAfunds 
MIR research 
Since 1986 the Radiolog- 
ical Society of North Amer- 
ica (RSNA) has awarded 
Research and Education 
Fund Grants to young inves- 
tigators as they begin careers 
in radiology research and 
education and in related sci- 
entific disciplines. 
David Feinberg, MD, 
PhD, instructor in radiology, 
received an RSNA Scholar 
Award of $60,000 annually 
for two years for his study of 
"Fast MRI scanning: devel- 
opment and clinical evalua- 
tion." Faculty members of 
North American institutions 
who are in the first five 
years of their academic 
careers are eligible for the 
Scholar Award. 
David Hillier, MD, PhD, 
assistant in radiology, is the 
recipient of a Roentgen Resi- 
dent/Fellow Research 
Award, which is presented 
annually to individuals who 
have distinguished them- 
selves with their early 
accomplishments in radio- 
logical investigation. The 
award was presented to 
Hillier, in collaboration with 
Jerold Wallis, MD, associate 
professor of radiology, for 
his assessment of the effects 
of liver uptake on myocar- 
dial perfusion imaging using 
Tc-99m sestamibi. 
Joshua Shimony, PhD, 
MD, assistant in radiology, 
received a Roentgen Resi- 
dent/Fellow Research 
Award for his investigations 
of diffusion-weighted mag- 
netic resonance (MR) imag- 
ing, which included the 
development of novel math- 
ematical and numerical pro- 
cedures for extracting 
information and analyzing 
data on diffusion anisotropy 
in the normal human brain. 
Thomas Conturo, MD, PhD, 
assistant professor of radiol- 
ogy and adjunct assistant 
professor of physics, served 
as scientific advisor. 
Katy Vo, MD, clinical 
neuroradiology fellow, was 
named a Mallinckrodt Med- 
ical/RSNA Fellow. The 
award is presented to a qual- 
ified young scientist nearing 
the completion of training 
and carries a $35,000 full- 
time stipend for one year, 
which will support Vo's 
research on "High resolution 
MR venography of occult 
venous malformations." 
FOCAL SPOT, FALL/WINTER, 1998 
MALUNCKRODT INSTITUTE OF RADIOLOGY (MIR) is OFFERING A 
NEW PROCEDURE THAT HAS THE POTENTIAL TO OFFER PAIN RELIEF 
AND MOBILITY TO THOSE WHO SUFFER FROM THE DEBILITATION 
CAUSED BY SPINAL BONE LOSS AND VERTEBRAL COMPRESSION 
FRACTURES.   ■   LOUIS GlLULA, MD, PROFESSOR OF RADIOLOGY 
AND OF ORTHOPAEDIC, PLASTIC, AND RECONSTRUCTIVE SURGERY, 
HAS EXPERIENCED A HIGH MEASURE OF SUCCESS IN TREATING 
SUCH PATIENTS WITH THE TECHNIQUE KNOWN AS PERCUTANEOUS 
VERTEBROPLAS T Y MIR MAKES PROGRESS IN TREATING BONE PAIN 
VERTEBROPLASTY (PVP), WHICH INVOLVES THE INJECTION OF A 
BIOCOMPATIBLE MATERIAL INTO SEGMENTS OF THE SPINE. THE 
INJECTION OF    POLYMETHYLMETHACRYLATE ( PM MA), A 
CEMENT-LIKE SUBSTANCE THAT HARDENS UPON DELIVERY, WORKS 
'TO SUPPORT WEAKENED OR DETERIORATING BONES AND FRAC- 
TURED OR COMPRESSED VERTEBRAE AND TO BLOCK THE PAIN 
CAUSED BY THE ABNORMAL VERTEBRA. IN 70 TO 90 PERCENT OF 
PATIENTS, PAIN IS RELIEVED OR COMPLETELY ALLEVIATED. 
BY   BRIDGET   MCDONALD 
A GROWING NEED 
Given the aging of the Ameri- 
can population and the increasing 
number of elderly persons being 
diagnosed with osteoporosis, as 
well as patients with metastasis to 
the vertebra, vertebroplasty is a 
procedure that could offer an 
improved quality of life for many 
patients who are immobilized by 
pain. A preferred alternative to 
surgery, vertebroplasty is virtually 
painless, less invasive than surgery, 
and, therefore, has a shorter recov- 
ery period. A variation of vertebro- 
plasty—a procedure known as 
cementoplasty—may have poten- 
tial in the treatment of a wide range 
of individuals with bone deteriora- 
tion and pain (typically from metas- 
tases) in areas other than the spine. 
"Cementoplasty has been useful in 
treating areas of the anatomy 
where surgery is not desirable, 
such as the pelvic area in patients 
with metastases," says Gilula, who 
also is chief of musculoskeletal 
radiology at MIR. 
"The prime candidate for verte- 
broplasty is someone who has 
experienced a painful fracture that 
cannot be managed with pain med- 
ication or a fracture that does not 
resolve itself with time," says 
Gilula. "It is also a consideration 
for the patient who becomes 
unable to function because of pain 
or the use of pain medication." 
Vertebroplasty, like cemento- 
plasty, has been effective when 
used in conjunction with radiation 
to treat tumors and cancer of the 
bone. PVP may also benefit heart- 
and lung-transplant patients who 
have experienced compression 
fractures following the use of oral 
steroids as part of an immunosup- 
pressive regimen or chronic 
condition. 
MOBILIZING THE IMMOBILE 
Vertebroplasty was introduced 
in the United States at the 1988 
annual meeting of the Radiological 
Society of North America. Although 
the procedure has been used 
widely and successfully for many 
years in Europe, vertebroplasty has 
only recently been performed at a 
few medical centers in this coun- 
try. Clinical results recorded by 
radiologists in France and in the 
United States show that the funda- 
mental advantage of vertebroplasty 
is pain relief. Improvement in 
walking following PVP was also 
noted, especially in those who 
were previously bedridden. 
Researchers believe that pain relief 
plays a major role in restoring the 
patient's ability to walk, which in 
turn improves the patient's general 
quality of life. 
IMPROVING DELIVERY 
Gilula says the use of PMMA to 
strengthen or replace lost bone is 
not a totally new development, 
even in the United States. The 
acrylic-based PMMA has been used 
as a bone filler in orthopaedics and 
dentistry for as many as 30 years. 
But the method of delivery used in 
vertebroplasty is fairly new in the 
U.S., and Gilula has worked to fine- 
tune the delivery system, using 
radiological viewing technologies 
for detailed precision during the 
procedure. 
A special type of PMMA must 
be used to allow placement of the 
substance through a needle. Using 
a 10- to 15-gauge needle to inject 
the acrylic cement through a small 
incision in the skin and into the 
problem area, radiologists at MIR 
are able to direct the flow of the 
injection as it occurs. With the 
visual aid provided by fluoroscopic 
FOCAL SPOT, FALL/WINTER, 1998 
VERTEBROPLASTY 
On a side view, a needle (arrow) is in place within a fractured 
vertebral body (arrowheads). 
On a side view of the vertebra, the white material (between 
arrowheads) is the methyl methacrylate which has been injected 
through the needle. 
On a frontal view of the vertebra, the needle (arrow) is within 
the vertebral body surrounded by the dense, white meythyl 
methacrylate (between arrowheads). 
On the frontal view of the vertebra after removal of the nee- 
dle, dense white methyl methacrylate (between arrowheads) is 
evident within the vertebral body. 
guidance—with or without com- 
puted tomography (CT), doctors 
can see not only where the injec- 
tion will work best but can actually 
watch the PMMA as it flows into 
the problem area, allowing for 
accurate placement and applica- 
tion of the substance. "The success 
of the procedure requires a marked 
attention to detail," says Gilula, 
"and every technique available is 
used to make the desired precision 
possible." In preparation for the 
procedure, patients undergo X-ray 
exams and various combinations of 
other imaging studies, including 
CT, magnetic resonance imaging, 
and isotope exams. 
Before injecting the PMMA, 
doctors first inject a contrast mate- 
rial or dye into the bone site to 
judge the accuracy of the desired 
location and to get a visual sense 
of the density of the bone area. It is 
important that the PMMA sub- 
stance does not seep into the blood 
system, so the ability to view the 
directional flow of the contrast 
injection prior to the actual cement 
injection is another safety feature. 
"If there is too much destruc- 
tion of the vertebra or if there is no 
structure for the PMMA to mold 
into, then the patient may not be a 
good candidate for the procedure," 
says Gilula. He stresses the need to 
evaluate each patient's situation 
individually. For instance, some- 
times a patient will feel pain in the 
back that is associated with nerve 
pain going into an extremity. 
According to Gilula, vertebroplasty 
may help the back pain but usually 
would not reduce pain in the hips, 
thighs, or legs of those particular 
patients. 
Vertebroplasty is performed 
under mild anesthesia that allows 
the patient to be awake while feel- 
ing either mild discomfort or no 
pain. "The patient's ability to tell 
the radiologist what he or she is 
feeling is one of the safety features 
of the procedure," says Gilula. The 
patient lies facedown during the 
procedure, which usually takes 
approximately two hours, and feels 
only enough sensation to let the 
doctor know if a nerve is touched 
or if more anesthesia is needed. 
Patients who undergo verte- 
broplasty can expect to go home 
usually the same day of the proce- 
dure, with no stitches and a simple 
Band-Aid® over their incision. 
Some patients experience immedi- 
ate relief from pain, while for oth- 
ers it may take two to three days 
before there is a noticeable 
decrease in pain. 
WEIGHING THE SIDE EFFECTS 
Any procedure that involves 
the spine has certain risk factors 
and vertebroplasty is no exception. 
But radiologists at Mallinckrodt 
Institute use every precaution to 
assure the procedure is delivered 
in the safest manner. The most 
common complication for verte- 
broplasty, especially for those 
patients with thoracic spine frac- 
tures, is rib fracture caused by the 
pressure needed to insert the nee- 
dle into the spine. Nothing can be 
done to prevent the rib fracture 
since most patients having this pro- 
cedure usually have weakened 
bones, but the fractures can be 
treated with pain medication and 
will eventually heal. More serious 
complications can involve bleeding 
and spinal cord injury, cement par- 
ticles entering the blood stream, or 
increased pain or further fracture 
of the bone being treated. But 
these more serious complications 
are exceedingly rare, says Gilula. 
The monitoring process during the 
procedure combined with the 
patient pre-evaluation make this a 
relatively safe and effective 
procedure. 
I 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
KILLING THE PAIN 
Although the success of verte- 
broplasty is usually attributed to 
the support and reinforcement of 
the bone provided by the hardened 
cement-like substance, Gilula says 
it is also likely that the heat created 
by the substance immediately after 
it is administered could play a part 
in the pain relief. "We know that 
the cement supports and holds the 
bone fragments apart so that they 
cannot rub together, and that alone 
can stop the pain. But it may also 
be that the heat generated by the 
hardening process kills the nerve 
ends that are causing the pain," he 
says, "and this is especially possi- 
ble since pain relief can be evident 
immediately after the procedure." 
"This procedure is a valuable 
new tool that will be more com- 
monly used in the future to treat 
bone pain," adds Gilula, "and radi- 
ologists at Mallinckrodt Institute 
are paving the way for these 
developments." Una 
Editor's note: Bridget McDonald is 
a Miami-based free-lance writer. 
FINDING PAIN RELIEF 
When Helen McCoy became incapacitated last winter following a fall 
on the ice while walking her dog, she became acutely aware of how 
pain can alter your life. "There were days when I couldn't make the bed," 
recalls the active 75-year-old great-grandmother. "And there were days I 
couldn't even get out of bed." 
After a visit to her family physician, a referral to an orthopaedic sur- 
geon and three sessions of physical therapy that she found too painful to 
pursue, Helen was referred to Dr. Louis Gilula, chief of musculoskeletal 
radiology at Mallinckrodt Institute of Radiology at Washington University 
Medical Center.   By that time, seven months after the fall that caused a 
vertebra to fracture, Helen was a prime candidate for vertebroplasty. Her 
fracture had healed on its own, but she was having constant pain. She 
found it difficult to do simple things like climb in and out of the bathtub. "It 
was painful to bend over at all," she says, "and nearly impossible unless I 
held onto something." 
Now, following vertebroplasty, Helen has returned to the healthy and 
active lifestyle she previously enjoyed. The procedure, says Helen, took 
only a few hours of recovery time and she felt no pain or discomfort during 
the injections. 
"I could see what Doctor Gilula was doing while he was doing it," says 
Helen, who watched the procedure on a monitor via fluoroscopy. "I was 
not totally sedated, but just given something to numb the pain. The staff 
told me step-by-step what they were doing." 
It took a little over an hour for Helen to recover from the treatment; 
she was allowed to sit up and shortly afterward went home. "It took a day 
or two for the pain /of the procedure] to completely disappear," she says. 
"But I didn't even need the pain medication Doctor Gilula prescribed." 
She experienced no side effects or complications from the treatment 
and today has resumed her life as it was prior to the fall. "I can bend and I 
can sit up straight with no pain," Helen says. "It's great. I feel no pain in 
that area at all." EH 
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1 tiLCiy tit(y making an investment and knowing in advance what your 
return will be or planting a crop and determining the yield before the first seed 
germinates. Researchers at Mallinckrodt Institute of Radiology (MIR) and 
Washington University School of Medicine (WUSM) are doing just that in the 
treatment of advanced breast cancer. Using tamoxifen, the most commonly pre- 
scribed anti-cancer agent, and a noninvasive radiology technique called positron 
emission tomography (PET) that provides vivid functional images of various 
organ systems, researchers can predict within two weeks of initiation of treat- 
ment whether or not the therapy will work. This breakthrough enables patients 
who do not respond to tamoxifen therapy to pursue other avenues of treatment 
without wasting precious months or even weeks. 
by Kirstin Blase 
TAMOXIFEN'S EFFECTIVENESS 
In a recent scientific paper, "PET 
assessment of 'metabolic flare' to 
predict response of metastatic 
breast cancer to antiestrogen ther- 
apy," Mallinckrodt Institute's Far- 
rokh Dehdashti, MD, associate 
professor of radiology, describes 
the use of PET in determining the 
effectiveness of tamoxifen therapy 
by a response called "metabolic 
flare" in the patient. Metabolic 
flare is indicated on the PET image 
by an increased uptake of fluo- 
rodeoxyglucose (FDG), a radioac- 
tive form of sugar that is absorbed 
faster by malignant tissues than by 
normal tissues. It is from this flare 
reaction that a positive response to 
the treatment can be expected. 
The paper was coauthored by 
MIR's Barry Siegel, MD, and 
Michael Welch, PhD; Fidelma 
Flanagan, MRCPI, FRCR, Univer- 
sity Hospital, Dublin, Ireland; 
Joanne Mortimer, MD, WUSM 
Department of Internal Medicine; 
and John Katzenellenbogen, PhD, 
University of Illinois, Champaign- 
Urbana. 
Using PET and fluoroestradiol 
(FES), a radioactive form of estro- 
gen developed as a PET imaging 
agent by Welch and Katzenellenbo- 
gen, researchers also are able to 
determine if a breast tumor is 
estrogen receptor (ER) positive— 
an important discovery because 
estrogen, a naturally occurring hor- 
mone, is believed to promote the 
growth of breast cancer cells. 
Tamoxifen acts like both estro- 
gen and antiestrogen. Like FES 
and estrogen, tamoxifen binds to 
the estrogen receptors on the 
tumor, but the drug's antiestrogen 
characteristics block the receptor, 
acting as an antagonist in the 
tumor to slow or prevent tumor 
growth. 
According to Dehdashti, whose 
research is funded by the 
National Institutes of Health, 30 to 
40 percent of patients with breast 
cancer are ER positive and are 
likely to respond to tamoxifen ther- 
apy. PET images using FES and 
FDG were taken of each woman in 
the study before initiation of her 
tamoxifen therapy. The images 
were repeated seven to ten days 
after therapy began, at which point 
metabolic flare could be deter- 
mined. Those women with positive 
metabolic flare reactions continued 
tamoxifen treatment; those who 
had negative reactions were 
changed to a different type of ther- 
apy, thus saving valuable time. 
Another important finding is 
the identification of "clinical flare," 
which is similar to metabolic flare 
but signals the possible onset of 
disease remission. Clinical flare is 
characterized by pain in the tumor 
site and in areas surrounding the 
tumor, making it difficult to differ- 
entiate clinical flare from disease 
progression. Since clinical flare 
occurs in less than 20 percent of 
patients, the discovery of the reac- 
tion of metabolic flare is important 
in saving time and unnecessary 
treatment. 
REDUCING RISK 
In women who have an increased 
risk of developing breast cancer, 
tamoxifen's antiestrogen character- 
istics are helpful in reducing their 
chance of developing the disease. 
In women who have been diag- 
nosed with breast cancer, tamox- 
ifen therapy can prevent a 
recurrence of the original breast 
cancer as well as prevent metasta- 
sis in the opposite breast. If you 
consider that approximately 110 
women out of every 100,000 will be 
diagnosed with breast cancer this 
year, then Dehdashti's and Welch's 
findings become paramount in 
fighting this disease. Even though 
tamoxifen has been in use for the 
treatment of breast cancer since 
1978, it was not until October, 
1998, that the U.S. Food and Drug 
Administration approved its use for 
prevention in high-risk patients. 
According to a recent study per- 
formed at the National Cancer 
Institute, tamoxifen has shown the 
ability to reduce the risk of breast 
cancer by 44 percent. 
WEIGHING THE BENEFITS 
The danger in the widespread 
use of tamoxifen as a preven- 
tion for breast cancer is that for 
healthy low-risk women, the possi- 
ble side effects may outweigh the 
benefits. Although for women at 
high risk for breast cancer, preven- 
tion with tamoxifen might be con- 
sidered based on the drug's record 
as a treatment as well as the new 
statistics on its preventive abilities. 
For 20 years and counting, MIR 
and WUSM researchers have been 
pioneers in the study of the treat- 
ment and prevention of breast can- 
cer using tamoxifen. "Pharmacol- 
ogically speaking, tamoxifen is 
very complicated," says Welch. 
"For this reason, the world can 
expect research to continue for at 
least another two decades." 
FOCAL SPOT, FALL/WINTER, 1998 
Farrokh Dehdashti, MD 
XIFEN 
Michael Welch, PhD 






Joanne Mortimer, MD 
Patient has primary breast cancer in her right breast  The above images arc transaxial 
images at the level of the cancer. FDG image (left) shows markedly increased glucose 
metabolism in the breast lesion, consistent with breast cancer. FES image (right) shows 
markedly increased activity in the tumor consistent «ilh high levels of estrogen receptors 
in the tumor   The green color on the right image is normal Wood pool activity. 
CONCURRENT TAMOXIFEN 
RESEARCH 
Not only does menopause 
increase a woman's risk of breast 
cancer, it also puts her at risk of 
developing other common diseases 
such as osteoporosis and senile 
dementia of the Alzheimer's type 
(SDAT). And a possible antiestro- 
gen side effect of tamoxifen is 
memory loss. Because estrogen is 
important to memory and brain 
function, women receiving estro- 
gen hormone replacement therapy 
have shown a reduced incidence of 
developing SDAT. According to 
Mortimer, who is clinical director 
of WUSM's Division of Medical 
Oncology, there is some concern 
when 60 to 70 percent of women 
taking tamoxifen experience mem- 
ory loss. In collaboration with 
Welch, professor of radiology, of 
chemistry, and of molecular biol- 
ogy and pharmacology, and with 
Marcus Raichle, MD, professor of 
radiology and of neurology and 
neurobiology, and Mark Minutn, 
MD, associate professor of radiol- 
ogy, Mortimer recently received a 
research grant from the Dana 
Foundation to assess the effects of 
tamoxifen on cognitive functioning. 
Welch's research team, whose 
study is funded by the U.S. Depart- 
ment of Energy, used PET and 
FES to highlight estrogen receptors 
in the hypothalamus area of a 
baboon's brain. When using these 
same tools to image a woman's 
brain, Mortimer expects to see 
estrogen receptors concentrated in 
the region known as the hippocam- 
pus, which is responsible for 
memory. 
The researchers also will use 
PET and FDG to image a woman's 
brain after initiation of tamoxifen 
treatment in order to capture a 
metabolic flare response similar to 
that found in breast cancer. After 
initiation of treatment, FES uptake 
will decrease as tamoxifen binding 
to the ERs will increase. At the 
same time, FDG uptake (glucose 
metabolism) increases. The results 
of Mortimer's study will help in 
understanding how glucose metab- 
olism and brain function are 
closely related. 
The images will allow 
researchers to see which parts of 
the brain contain ERs or where 
tamoxifen is binding in the brain. 
If tamoxifen is acting as an antie- 
strogen in the brain and is binding 
to sites that regulate memory, its 
use as a preventive agent may need 
to be reviewed and reconsidered. 
Tamoxifen's antiestrogen proper- 
ties might have the same effect on 
short-term memory in menopausal 
women as that caused by lowered 
concentrations of estrogen. 
"Menopausal women often com- 
plain about not remembering peo- 
ple's names, being slower at 
working crossword puzzles, not 
having immediate recall, or having 
difficulty in finding their car in the 
parking garage," says Mortimer. 
"Since American women are living 
longer and will spend one-third of 
their lives postmenopause, our 
research findings are significant." EH3 
Editor's note: Kirstin Blase is cur- 
rently working as a medical 
research technician in MIR's Radi- 
ological Chemistry Laboratory. 
POSSIBLE side effects 
OF TAMOXIFEN 
As in premenopausal women 
whose bodies are still producing 
estrogen, tamoxifen's estrogen side 
effects may include the following: 
■ Lowered blood cholesterol. 
■ Increased bone density. 
■ Prevention of the recurrence 
of original breast cancer as 
well as new cancers in the 
opposite breast. 
■ Reduced number of cases of 
invasive breast cancer. 
■ Possible increased fertility in 
premenopausal women. 
■ Increased risk of developing 
uterine cancer. 
As is the case with menopause, 
not all women who take tamoxifen 
have these symptoms: 
■ Hot flashes and vaginal 
discharge. 
■ Irregular menstrual periods. 
■ Dizziness, headaches. 
■ Fatigue and loss of appetite. 
■ Vaginal dryness or bleeding. 
■ Possible blood clots. 
(Research studies suggest a 
small increase in number of 
blood clots in women taking 
tamoxifen, particularly in 
women who are receiving 
chemotherapy drugs along 
with tamoxifen.) 
■ Depression. (Reported in one 
percent of postmenopausal 
women using tamoxifen.) 
■ Slight increase for developing 
cataracts. (As women age, 
they are more likely to 
develop cataracts whether or 
not they take tamoxifen.) 
This information was extracted 
from the National Cancer Insti- 
tute's Cancer Facts. 
FOCAL SPOT, FALL/WINTER, 1998 
I III PROTON BEAMS, 
A NEW APPROACH TO 
CANCER THERAPY 
Samuel Au, MD, PhD, a 
resident in MIR's Radiation 
Oncology Center, received 
the 1998 American College 
of Radiation Oncology Fel- 
lowship, which sponsored 
a rotation in proton therapy 
at Loma Linda University 
Medical Center in Califor- 
nia.  Proton therapy is a 
form of cancer treatment 
that uses protons created 
by a special acclerator to 
deliver high doses of radi- 
ation to a tightly confined 
tumor site, thus reducing 
the side effects of the 
treatment while destroying 
diseased cells.  In the fol- 
lowing article, Au shares 
his thoughts about this 
exciting technology and 
his experiences at the only 
clinical proton therapy 
facility   in   the   United 
States. 
I have read about protons and charged 
I particle beams in cancer treatments 
and was fascinated by their physical 
properties. They are especially important 
in the treatment of surgically inaccessible 
cancers. There are centers in Europe, the 
United States, and South Africa with such 
therapeutic modality. I chose to spend my 
two-month elective at Loma Linda Univer- 
sity Medical Center (LLUMC) in California 
to learn firsthand about their proton facil- 
ity. Currently, LLUMC houses the only 
clinical proton facility in the United 
States; however, Masssachusetts Gen- 
eral Hospital (MGH) has a lower energy 
level proton facility that is currently used 
for radiation treatment. MGH plans to 
open a modern clinical facility soon. 
I have seen an artist's depiction of 
MGH's proposed proton facility, which 
highlights the center's structural com- 
plexity. I am still in awe every time I see 
the gigantic cyclotron and gantry struc- 
tures of LLUMC's proton treatment facil- 
ity. The cyclotron, as expected, is sizable. 
The gantry mechanisms and supporting 
structures above the treatment rooms are 
three to four stories high. Besides the 
advanced technology and science 
involved, the proton treatment facility is 
an engineering monument in itself. Since 
the medical center is within a few miles 
of the San Andreas Fault Line, the proton 
facility is designed structurally to with- 
stand the worst foreseeable earthquake. 
A proton beam, by virtue of its Bragg 
peak (a term used to describe the 
energy deposit pattern of the beam), 
offers the unique capability of deliver- 
ing high dose radiation to a target vol- 
ume deep inside a patient's body while 
keeping the dose to the adjacent 
organs relatively low. The entrance 
dose, compared to that of a photon 
beam, is substantially lower. In addition, 
the beam terminates abruptly with zero- 
exit dose after depositing all of its 
energy in the target. By modulating the 
beam with a rotating disc, the width of 
its Bragg peak is matched spatially to 
cover the target volume. In three- 
dimensional conformal therapy, proton 
beams are truly 3-D conformal beams. 
As photon beams, they conform to the 
cross-sections of the targets. In addi- 
tion, the depths of their penetration and 
the lengths of energy deposition are 
matched to the longitudinal dimension 
of the target volume. This is imple- 
mented with a custom bolus shaped to 
compensate for the irregular thickness 
of the target volume. 
The proton beams also possess 
the desirable feature of extremely 
sharp beam edges. Unlike photon 
beams that have penumbra and angular 
divergence, proton beams are made up 
of parallel aligned particles—with 
essentially no divergence or penumbra. 
In particular, the portion of the beam 
before the Bragg peak is especially 
LLUMC has developed its 
own 3-D treatment planning 
system for proton and photon 
therapy, fully accounting for 
the difference in each 
therapy's dosimetry and 
physical attributes. 
sharp-edged and practically a "parallel 
pencil beam." This portion of the beam 
is frequently used in the highly precise 
stereotactic radiotherapy used to treat 
critical targets. The Bragg peak, by 
design, is placed outside of the 
patient's body after the beam has 
exited the patient. The importance of 
the beam's sharp edges cannot be 
understated in treatment of tumors 
around critical structures such as the 
spinal cord, the optic nerves, the chi- 
asm and essential tissues in the central 
nervous system. While covering the 
tumor volume in its entirety, the beams 
have to necessarily avoid the neighbor- 
ing critical organs and structures. The 
beam's sharp edge geometrically offers 
the highest therapeutic ratios in these 
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cases. Very often, this spatial advantage 
presents the only feasible treatment 
plan adequate for the target, without 
causing unacceptable collateral injury 
to surrounding critical structures. 
To achieve the full spatial benefits of 
proton beams, the treatment plan- 
ning is necessarily done and optimized 
in a computerized 3-D system. The 
placement of beams, their orientations, 
and distributions are limited only by the 
physical limitations and degrees of free- 
dom of the gantry, collimator, and treat- 
ment table. The coverage of target and 
dose homogeneity can be optimized in 
the process of virtual simulation using 
the stored images of the patients. This 
shortens the uncomfortable time 
patients spend lying on a simulation 
table while clinicians determine the best 
treatment geometry. This virtual proce- 
dure also alleviates the heavy demand 
on support personnel and allows more 
efficient use of simulation resources. 
With the advancement of image pro- 
cessing techniques, delineation of tar- 
gets and critical organs to a high degree 
of precision and accuracy is feasible 
with the fusion of various imaging 
modalities, including ultrasound, com- 
puted tomography, and magnetic reso- 
nance imaging. 
LLUMC has developed its own 3-D 
treatment planning system for proton 
and photon therapy, fully accounting 
for the difference in each therapy's 
dosimetry and physical attributes. As 
do other commercially available photon 
planning systems, LLUMC's system 
offers the full spectrum of computa- 
tional and 3-D display features. One 
can readily appreciate that its design 
stems from years of three-dimensional 
treatment planning experience. In my 
opinion, it has achieved the user- 
friendly criterion of "bringing together 
and connecting man and machine in 
continuum." 
The striking aspect of this system is 
that it is a PC window-based sys- 
tem. All the PCs in the department are 
connected in a local network, exploit- 
ing to the maximum the current com- 
puter-network technology. An 
authorized user can access the full 
capacity of any PC in the network from 
his or her terminal. Using a home PC, a 
physician can outline a gross tumor in 
the comfort of his or her own home, 
plan the treatment, and still enjoy a 
family dinner. With the availability of 
high-data-rate communication technol- 
ogy and the Internet, the idea of 
transcontinental telemedicine in radia- 
tion therapy is not a farfetched idea. 
One of the challenging issues in 
high-dose conformal radiotherapy is 
dealing with internal target-organ 
movements or target-position changes 
between treatments, such as occurs in 
high-dose conformal prostate therapy. 
Currently, ultrasonic imaging of the 
prostate prior to every treatment in 
order to facilitate better targeting is 
being studied in some treatment cen- 
ters. Other centers approach this prob- 
lem by increasing the (beam) portal 
margins to account for the prostate's 
change of position. The sensitive rec- 
tum, which is immediately posterior to 
the prostate, is mobile and tends to 
move freely with the prostate. The 
increase of margin around the target 
prostate will result in an increase of 
exposure to the rectum. A proactive 
technique is used at LLUMC, whereby a 
rectal balloon is applied onto the 
prostate. The balloon places the target 
prostate in a more consistent repro- 
ducible position relative to the bony 
landmarks. It also displaces a major 
portion of the rectal wall away from the 
target prostate and seminal vesicles, 
thereby minimizing the unnecessary 
exposure to the rectum. LLUMC's thera- 
peutic results in terms of tumor control, 
complications, and patient satisfaction 
have been excellent and comparable 
with some of the best published results 
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in scientific literature. It will be interest- 
ing to see the comparative results of 
various approaches in the future. If 
LLUMC's rectal balloon technique 
proves beneficial, it can readily be 
deployed with the transrectal ultra- 
sound approach. 
The supporting technology and 
methodology that make the best and 
most optimal use of proton therapy as a 
standard treatment modality for can- 
cers are advancing rapidly. It would not 
be surprising to have multileaf collima- 
tors, reverse planning, beam intensity 
modulation, and similar technology for 
proton therapy available within the next 
few years. At LLUMC, a real-time por- 
tal imaging system has already become 
a standard portion of the daily treat- 
ment operation. Staff physicians rou- 
tinely verify and fine-tune the isocentric 
setup so that daily setup variations are 
minimized. At first glance the proce- 
dure is labor-intensive, but operational 
practice experience suggests that it 
can be very efficient with a fully trained 
team. 
Another technology deployed at 
LLUMC for efficient treatment 
delivery is a bar-code system for each 
patient's chart, treatment blocks, cus- 
tom bolus, and immobilization cradle. 
As a daily quality assurance control 
measure, therapists scan the bar codes 
on every medical-related article of the 
patient's information before treatment 
begins. The bar-code system improves 
efficiency and daily patient setups and 
is a simple safeguard for any day-to- 
day human errors. 
During the two months I spent at 
LLUMC, I was very impressed with the 
weekly treatment planning review. For 
every case, the tumor and isodose vol- 
umes with surface rendering were 
selectively projected onto a room-size 
screen, and the clinical staff partici- 
pated in a lively discussion and 
exchamge of ideas for planning the 
beams and treatment geometry. This 
The supporting technology 
and methodology that make 
the best and most optimal 
use of proton therapy as a 
standard treatment 
modality for cancers are 
advancing rapidly. 
took experience and insight into the 
planning of each case since there was 
never a textbook case. 
Proton as a modality in radiation ther- 
apy has not been an option in the 
less developed countries, and its 
unavailability in the Third World coun- 
tries is largely due to economics as well 
as the lack of properly trained physi- 
cians and support personnel. Asia, with 
its large population, has one of the high- 
est incidence rates of head and neck 
cancers in the world. Physicians 
trained in proton therapy will be essen- 
tial in establishing and making available 
such treatment options to the public. 
Currently in Taiwan, Japan, and soon in 
China and other Third World countries, 
concrete plans to implement this tech- 
nology are being generated. 
My goal is to use my scientific 
knowledge to bring medical technology 
and newly available medicine to Asia, 
where I was born and raised. I am 
thankful for the opportunity to have 
observed LLUMC's world-class proton 
facility and the application of various 
advanced technologies for efficient 
treatment delivery. I am grateful to 
LLUMC's staffs and residents for making 
my rotation such a profound learning 
experience and to the American College 
of Radiation Oncology Committee for 
sponsoring my rotation. EH 
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Laura Ruhrwien 
From the moment a BJC Health 
System™ patient makes an 
appointment for a radiologic exam, 
Mallinckrodt Institute of Radiology 
(MIR) computers are at the very 
heart of the process. The comput- 
ers record the scheduling data, the 
patient's arrival, and the written 
test results. They supply back- 
ground on the patient's medical 
history to the physician, and they 
even provide a link to billing once 
the exam is complete. 
"All of this information used to 
be handled with pieces of paper," 
says Gilbert Jost, MD, professor of 
radiology and chief of MIR's Divi- 
sion of Diagnostic Radiology. "Not 
only is this computer record more 
efficient, but it also gives us an 
opportunity to access patient data 
electronically from any point in the 
system." 
This radiology system relies 
upon the work of a behind-the- 
scenes group: MIR Computer 
Facilities. This busy service pro- 
vides information systems (IS) sup- 
port for 400 MIR users located at 
Barnes-Jewish, Barnes-Jewish 
St. Peter's, and St. Louis Children's 
hospitals as well as 600 users in 
BJC's central region. 
And as if this were not enough, 
the computer group itself has 
recently undertaken a major reor- 
ganization, a planned move to the 
Institute's East Building, and a 
major shift in focus to new activi- 
ties and a broader mission. "We 
are growing—and not just growing 
and doing the same thing. We're 
adding a number of services, which 
we're delivering in a cost-effective 
manner," says Laura Ruhrwien, 
director of informations systems at 
MIR who has expertise in manag- 
ing IS systems and creating busi- 
ness plans that contain strong 
cost-benefit analysis. 
"The revitalized emphasis on 
computer facilities comes at a time 
when some institutions are backing 
away from leading-edge involve- 
ment in computer technology. MIR 
historically has been an informa- 
tion systems leader and, in the mid- 
1970s, was among the first 
radiology departments worldwide 
to develop and install information 
systems, says Jost. "We intend to 
maintain its reputation as a leader 
in this area." 
"It is most unusual for a radiol- 
ogy department to have a computer 
group as large and as vigorous as 
this one," Jost adds. "But we feel 
that this technology is going to be 
at the heart of our specialty for 
years to come, and that having a 
strong IS group will enable us to 
deal with a host of challenges down 
the road." 
There were eight computer staff 
when Ruhrwien arrived at MIR 
in November of 1997, but she plans 
to increase that number to 19 by 
the end of 1999. Under Ruhrwien's 
leadership, the group has reorga- 
nized into a three-tier structure: 
One group now handles the "Help 
Desk" function, answering 50 to 
100 calls each day. They log all 
calls, respond as quickly as possi- 
Tracy Duckett, a user support technician 
ble, and work with users to spot 
potential trouble and to eliminate 
routine problems. Eighty percent 
of the problems can be solved in a 
single business day; the other 20 
percent are referred to a second- 
tier group who tackle large pro- 
jects that may take from one day to 
three weeks to resolve. 
The third group covers major 
projects that are part of a new 
four-year plan developed by 
Ruhrwien, Jost, and James Blaine, 
DSc, professor of radiology and 
director of MIR's Electronic Radi- 
ology Laboratory (ERL). This third 
group just completed a year-long 
project to convert Children's Hos- 
pital from the MIR radiology infor- 
mation system that had been 
developed in-house to a newer, 
easier-to-maintain system called 
IDXrad, which is offered by an out- 
side vendor. This group was no 
stranger to large, complicated pro- 
jects since they had previously 
completed a system conversion at 
Barnes-Jewish Hospital (BJH) in 
June, 1996, and another at BJH 
West County in May, 1997. Next up 
is the conversion of the informa- 
tion system for the BJH-sponsored 
Breast Health Center as well as the 
system for the mammography van. 
"The Children's conversion 
was our third project," says Steve 
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Steve Rodewald 
Rodewald, a systems analyst who 
has been with the computer group 
since 1980. "Our experience pays 
off each time we handle a more 
complicated conversion." 
One key to success of the Chil- 
drren's Hospital project was taking 
data from the old system— 
affectionately known as "REXrad" 
for Rex Hill, the system's developer 
and former head of the computer 
group—and loading it on IDXrad so 
that users had easy access. A sec- 
ond key was the staging of a full- 
scale simulation of the system a few 
weeks prior to "going live." This 
afforded the group a sense of how 
IDXrad would operate. 
Another large, complicated pro- 
ject just now beginning 
involves working with the ERL on 
Project Spectrum, a collaborative 
partnership among BJC, MIR, and 
Washington University School of 
Medicine. Project Spectrum will 
ultimately provide integrated 
patient information and images to 
physicians in the BJC system. The 
ERL is charged with the electronic 
imaging aspect of this project: to 
facilitate a major shift from film- 
based to digital images. 
BJC's Information Technology 
group has been storing standard 
BJC patient data, laboratory tests, 
demographics, and vital statistics in 
a clinical information repository. At 
the same time, the ERL group is cre- 
ating an image repository, so that 
the primary care physician can have 
desktop access, through a simple 
click of an icon, to radiologic 
images cited on a patient's chart. At 
the moment, some 450 clinical 
workstations, located in physicians' 
offices and homes, provide access 
to these written and visual records. 
Within the next year, this pro- 
ject will be taken a step fur- 
ther: The ERL will provide its 
developmental support to the Com- 
puter Facilities staff, and the two 
groups will work together closely to 
develop and support a filmless envi- 
ronment at MIR. To make this col- 
laboration easier, the computer 
group will move in early 1999 from 
their cramped quarters in the Clini- 
cal Sciences Research Building to a 
larger space in the East Building on 
Scott Avenue, placing them adjacent 
to the ERL. 
"One of the goals for Computer 
Facilities is to accomplish the tran- 
sition from the research and devel- 
opment area into production," says 
Blaine. "I believe that Laura is tak- 
ing a very professional approach to 
defining requirements and activat- 
ing plans that will achieve this goal." 
The computer group also will 
be undertaking several other big 
projects, including Satellite Radiol- 
ogy Services that is slated to begin 
in summer of 2000 and is aimed at 
developing new procedures so that 
MIR can add client groups, such as 
health care facilities, for whom MIR 
will provide fast and inexpensive 
radiologic services. Another project, 
still in the planning stage, is a com- 
plete changeover of MIR desktop 
services, in an effort to make the 
workplace more efficient by stan- 
dardizing software and hardware. 
As part of this project, all MIR 
employees will receive a new com- 
puter, along with a uniform version 
of software and a brand-new elec- 
tronic-mail system. 
Prapapun "Pun" Wilson, a programmer 
Ruhrwien also believes that 
another opportunity for improve- 
ment is in the area of management 
reporting. The computer staff will 
soon begin work on a new system 
that will make it easier to evaluate 
performance, to provide managed- 
care and outcomes analysis, and to 
merge clinical and financial data. 
"The more information we can pro- 
vide to BJC management and to the 
radiologists, the more efficiently 
they can do their work," says 
Ruhrwien. 
With all of these changes 
already in progress, and with 
those that are anticipated, it is 
appropriate that the Computer 
Facilities group may adopt a new 
name—Radiology Information and 
Imaging Services—that is indicative 
of the wide range of services the 
group provides. It has been a hec- 
tic, sometimes frustrating, first year, 
Ruhrwien admits. But on days 
when she can pause to reflect upon 
it, she also realizes that all this work 
and planning for the future has actu- 
ally been enjoyable. 
"Now that we have our vision in 
mind and many people are on board 
with our ideas, it is exciting to cre- 
ate this new organization and to 
think about the strategic impor- 
tance and value we can provide 
both to BJC and MIR," she says. Ell 
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Robert Thompson, MD, 
associate professor of 
surgery (general surgery) 
and of cell biology and physi- 
ology, was appointed as 
associate professor of radiol- 
ogy, Division of Diagnostic 
Radiology. 
CHANGE IN STATUS 
Harold Bennett, MD, PhD, 
assistant professor of radiol- 
ogy (investigator), was 
appointed assistant profes- 
sor of radiology (clinical), 
Division of Diagnostic 
Radiology. 
DeWitte Cross, MD, assis- 
tant professor of radiology 
(investigator), was 
appointed assistant profes- 
sor of radiology (clinical), 
Division of Diagnostic 
Radiology. 
David Hovsepian, MD, 
assistant professor of radiol- 
ogy (investigator), was 
appointed assistant profes- 
sor of radiology (clinical), 
Division of Diagnostic 
Radiology. 
Clayton Hunt, PhD, assis- 
tant professor of radiology 
(investigator), was 
appointed assistant profes- 
sor of radiology (research), 
Radiation Oncology Center. 
Janice Semenkovich, MD, 
assistant professor of radiol- 
ogy (investigator), was 
appointed assistant profes- 
sor of radiology (clinical), 
Division of Diagnostic 
Radiology. 
NEW FACULTY 
David Feinberg, MD, assis- 
tant professor of radiology, 
Division of Diagnostic 
Radiology. 
Pilar Herrero, MS, 
research scientist, Division 
of Radiological Sciences. 
Suresh Vedantham, MD, 
assistant professor of radiol- 
ogy, Division of Diagnostic 
Radiology. 
OFF STAFF 
Mary Graham, MD, assis- 
tant professor of radiology, 
Radiation Oncology Center. 
Celette Sugg Skinner, 
PhD, assistant professor of 
radiology, Division of Radio- 
logical Sciences. 
Rao Vallabhaneni, PhD, 
instructor in radiology, 
Division of Radiological 
Sciences. 
Thomas Conturo, MD, 
PhD, assistant professor of 
radiology and adjunct assis- 
tant professor of physics, 
was appointed director of 
the MIR Summer Research 
Program. Now in its fifth 
year, the program offers 
medical students and sci- 
ence undergraduates an 
introduction to different 
aspects of radiological sci- 
ences research. 
Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal radiology, and codirec- 
tor of body computed 
tomography, was elected 
vice president-elect desig- 
nate of the Society of Com- 
puted Body Tomography 
and Magnetic Resonance at 
the society's annual meeting 
in Rancho Mirage, Califor- 
nia. He was appointed by 
the Board of Governors of 
the Radiological Society of 
North America (RSNA) to 
serve on the Gastrointestinal 
Subcommittee of the RSNA 
Program Committee. 
Gilbert Jost, MD, profes- 
sor of radiology and chief of 
the Division of Diagnostic 
Radiology, was appointed 
chairman of the Radiological 
Society of North America's 
(RSNA) Electronic Commu- 
nications Committee. The 
committee is responsible for 
the InfoRAD exhibit at 
RSNA's annual meeting as 
well as a variety of com- 
puter- and electronic com- 
munication-related projects 
throughout the year. 
Eric Klein, MS, assistant 
professor of radiology, was 
appointed to a three-year 
term as a member of the 
American Board of Medical 
Physics. He also was 
appointed as a member of 
the Continuing Education 
Committee and of the Pro- 
gram Committee of the 
American Association of 
Physicists in Medicine 
(AAPM) and as scientific 
codirector for the 1999 
AAPM Annual Meeting. 
Robert McKinstry, MD, 
PhD, instructor in radiology, 
was appointed to the 
National Institutes of 
Health/National Institute of 
Mental Health Technical 
Evaluation Panel. 
Eduardo Moros, PhD, 
assistant professor of radiol- 
ogy, was appointed chairman 
of the Symposium on Model- 
ing of Mass Transfer in Bio- 
logical Systems and of the 
Symposium on Modeling of 
Heat Transfer in Biological 
Systems for the International 
Mechanical Engineering 
Congress and Exposition 
held November 15 - 20 in 
Anaheim, California. 
David Piwnica-Worms, 
MD, PhD, professor of radi- 
ology and of molecular biol- 
ogy and pharmacology, and 
director of the molecular 
pharmacology laboratory, 
was appointed as a member 
of the Washington University 
Cancer Center Executive 
Committee and of the Wash- 
ington University School of 
Medicine Medical Scientist 
Training Program's Admis- 
sions Committee. He was 
reappointed as a member of 
the Radiological Society of 
North America's Research 
Development Committee. 
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William Reinus, MD, asso- 
ciate professor of radiology, 
was appointed comoderator 
of the "GI pathology and 
radiology in the next millen- 
nium" course at the Ameri- 
can College of Gastro- 
enterology Annual Meeting 
held October 9. 
Joseph Roti Roti, PhD, 
professor of radiology, asso- 
ciate director of the Radia- 
tion Oncology Center, and 
chief of cancer biology, was 
appointed as a panel mem- 
ber of the FDA Inneragency 
Working Group on the 
Progress of Wireless Tech- 
nology Research, which con- 
vened in Washington, DC, on 
November 12 and 13. 
Marilyn Siegel, MD, pro- 
fessor of radiology and of 
pediatrics, was appointed to 
a two-year term as treasurer 
of the International Cancer 
Imaging Society. 
Pamela Woodard, MD, 
assistant professor of radiol- 
ogy, was appointed to the 
Society for Cardiovascular 




Joshua Shimony, PhD, 
MD, assistant in radiology, 
received a $90,724 grant 
from the Spinal Cord 
Research Foundation, which 
is sponsored by the Para- 
lyzed Veterans of America, 
for research on "Diffusion 
imaging of the cervical 
spinal cord." Coinvestiga- 
tors for the two-year grant 
are Erbil Akbudak, PhD, 
research instructor in radiol- 
ogy; Abraham Snyder, 
PhD, MD, research scientist 
of radiology; and Thomas 
Conturo, MD, PhD, assis- 
tant professor of radiology 
and adjunct assistant profes- 
sor of physics. 
David Piwnica-Worms, 
MD, PhD, professor of radi- 
ology and of molecular biol- 
ogy and pharmacology, and 
director of the molecular 
pharmacology laboratory, as 
principal investigator, 
received a $254,000 renewal 
grant from the U.S. Depart- 
ment of Energy Molecular 
Nuclear Medicine Program. 
Coinvestigators for the 
research on "Targeting mul- 
tidrug resistance with metal 
complexes" are Vijay 
Sharma, PhD, research 
assistant professor of radiol- 
ogy; Valery Polyakov, 
PhD, research associate; 
Kathryn Luker, PhD, 
research associate; and 
Julie Dahlheimer, senior 
medical research technician. 
Douglas Spitz, PhD, assis- 
tant professor of radiology, 
as principal investigator, 
received a $1.3 million grant 
from the National Institutes 
of Health for research on 
"Nitric oxide-induced cell 
injury: molecular mecha- 
nisms." Coinvestigators for 
the grant are Prabhat 
Goswami, PhD, assistant 
professor of radiology, and 
Clayton Hunt, PhD, assis- 
tant professor of radiology. 
Sharlene Teefey, MD, 
associate professor of radi- 
ology, as principal investiga- 
tor, received a grant from 
the Society of Radiologists 
in Ultrasound for research 
on "Detection of rotator cuff 
and biceps tendon pathology 
in patients with a painful 
shoulder: a comparison of 
US, MRI, and arthroscopic 
surgery in 100 consecutive 
cases." Coinvestigators for 
the $40,000 grant are 
William Middleton, MD, 
professor of radiology; 
Scott Mirowitz, MD, asso- 
ciate professor of radiology; 
William Totty, MD, profes- 
sor of radiology; Vamsidhar 
Narra, MD, instructor in 
radiology; and Ken Yam- 
aguchi, MD, assistant profes- 
sor of orthopaedic surgery, 
Washington University. 
Jeffrey Williamson, PhD, 
professor of radiology, 
received a $1 million grant 
from the National Cancer 
Institute for research on 
"Integration of imaging tech- 
niques into treatment of 
locally advanced cervical 
cancer." Coinvestigators for 
the four-year grant are 
Harold Bennett, MD, PhD, 
assistant professor of radiol- 
ogy; Clifford Chao, MD, 
assistant professor of radiol- 
ogy; Joseph O'Sullivan, 
PhD, associate professor of 
electrical engineering and of 
radiology; James Dempsey, 
PhD, research associate; 
Carlos Perez, MD, profes- 
sor of radiology; Perry 
Grigsby, MD, professor of 
radiology; Donald Snyder, 
PhD, professor of electrical 
engineering and of radiol- 
ogy; Michael Vannier, MD, 
University of Iowa; Ge 
Wang, PhD, University of 
Iowa; Gary Christensen, 
DSc, University of Iowa; and 




Sharlene Teefey, MD, 
associate professor of radi- 
ology, was named a fellow 
of the Society of Radiolo- 











Heather Curry, MD, assis- 
t in radiology and assis- 
tant chief resident, radiation 
oncology, presented "Heat 
shock inhibits radiation- 
induced activation of DNA- 
binding and nuclear 
localization of NF-KB" at The 
Oxygen Society meeting, 
Washington, DC, November 
20. 
Colin Derdeyn, MD, assis- 
tant professor of radiology, 
spoke on "Imaging of stroke: 
evaluation of carotid artery 
disease" at the 6th Annual 
Update for the Clinician, 
Carbondale, Illinois, Novem- 
ber?. 
David Gierada, MD, assis- 
tant professor of radiology, 
presented "Quantitative CT 
assessment of emphysema in 
patients evaluated for lung 
volume reduction surgery" at 
Chest 1998, American Col- 
lege of Chest Physicians, 
Toronto, Ontario, Canada, 
November 8 -12. 
Louis Gilula, MD, profes- 
sor of radiology, of 
orthopaedic and plastic and 
reconstructive surgery, and 
chief of musculoskeletal 
radiology, spoke on "Cervi- 
cal nerve root spine blocks," 
"Introduction for interven- 
tional spine procedures," 
and "Radiofrequency facet 
dennervation of lumbar 
spine" at the International 
Skeletal Society Annual 
Meeting, Dublin, Ireland, 
September 5 -12. He pre- 
sented "MRI of wrist and 
hand," "MRI of foot and 
ankle," "Plain film approach 
to bone tumors," "Radiogra- 
phy of hand and wrist 
trauma," and "Known condi- 
tions of wrist and hand that 
should be recognized by 
radiologists" at A Meeting of 
Sociedade Brasileira de 
Radiologia, Rio de Janeiro, 
Brazil, October 24. 
David Gius, MD, instructor 
in radiology, presented 
"Redox regulation of AP-1 
DNA binding in HeLa and 
NIH3T3 cells in response to 
heat" at The Oxygen Society 
meeting, Washington, DC, 
November 20. 
Robert Gropler, MD, asso- 
ciate professor of radiology 
and director of the cardio- 
vascular imaging laboratory, 
presented "Effective report- 
ing of myocardial perfusion 
imaging to clinicians" at the 
Strategies for Effective 
Myocardial Perfusion Imag- 
ing in Managing Patients 
with Coronary Artery Dis- 
ease Symposium, sponsored 
by Mallinckrodt Institute and 
Washington University, St. 
Louis, Missouri, September 
19. He spoke on "Noninva- 
sive measurement of 
regional myocardial effi- 
ciency in the normal human 
heart" at the 71st Scientific 
Sessions of the American 
Heart Association, Dallas, 
Texas, November 8-11. 
Speaking for Pamela 
Woodard, MD, assistant 
professor of radiology, Gro- 
pler presented "New devel- 
opments in 3D coronary MR 
angiography using the MS325 
MR blood pool agent" at the 
25th Annual Meeting of the 
North American Society for 
Cardiac Imaging, Dallas, 
Texas, November 7. 
Mark Haacke, PhD, profes- 
sor of radiology and of elec- 
trical engineering and 
Melson Lecture 
Philip Rails, MD, head of the Division of Diagnostic Radiol- 
ogy at the University of Southern California-Los Angeles 
Medical Center, presented the Sixth Annual G. Leland Mel- 
son Visiting Professorship and Lecture on September 14 in 
MIR's Scarpellino Auditorium. Dr. Rails, who spoke on 
"Pancreatic sonography: What's New," was presented with 
a commemorative lecture plaque and is shown with Mrs. Lee 
Melson (Brenda) and Dr. Jay Heiken, chief of abdominal 
radiology and coordinator of the Melson Lecture. 
director of the magnetic res- 
onance imaging research lab- 
oratory, spoke on 
"Applications of 3D gradient 
echo imaging in observing 
lesion vascularity" at the Xth 
International Workshop on 
MRA, Park City, Utah, Sep- 
tember 30 - October 3. He 
presented "Understanding 
fMRI: its origins and its 
implications" at Baylor Col- 
lege of Medicine, Houston, 
Texas, November 17. 
Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal radiology, and codirec- 
tor of body computed 
tomography, presented "3D 
imaging: Why should we do 
it?" and "Hepatic masses: 
characterization with CT and 
MRI" at Digital Imaging 
Update, sponsored by Yale 
University, Brescia, Italy, 
September 28. He presented 
"CT evaluation of nontrau- 
matic gastrointestinal emer- 
gencies" to the South Central 
Kansas Radiological Society, 
Wichita, November 3. As 
visiting professor, Heiken 
spoke on "A practical 
approach to spiral CT of the 
abdomen" at the Wesley 
Medical Center, Wichita, 
Kansas, November 3. He 
presented "CT evaluation of 
nontraumatic abdominal 
emergencies" at Radiology 
Update for the Clinician, 
sponsored by Memorial Hos- 
pital of Carbondale, Carbon- 
dale, Illinois, November 7. 
Pilar Herrero, MS, research 
assistant professor of radiol- 
ogy, presented "Evaluation of 
myocardial kinetics of the 
hypoxic agent Cu-60- 
Diacetyl-Bis-(Ny-Methylth- 
iosemicarbazone) 
(Cu-ATSM)" at the 71st Scien- 
tific Sessions of the American 
Heart Association, Dallas, 
Texas, November 8-11. 
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Fiorenza Ianzini, PhD, 
assistant professor of radiol- 
ogy, spoke on "Radiation- 
induced mitotic catastrophe 
occurs to a reduced extent in 
cells with functional p53: 
implications for genomic 
instability" at the Workshop 
on Dose Response Relation- 
ships Involved in the Devel- 
opment of Radiation- 
induced Genomic Instability 
and the Implications for 
Radiation Protections, Capri, 
Italy, October 2 - 4. She pre- 
sented "Kinetics and magni- 
tude of mitotic castastrophe 
produced by exposure of V79 
Chinese hamster cells to 
high LET radiation" at the 
29th Meeting of the Euro- 
pean Society for Radiation 
Biology and 9th Meeting of 
the Italian Society for Radia- 
tion Research, Capri, Italy, 
October 3 - 7. 
Eric Klein, MS, assistant 
professor of radiology, pre- 
sented "New technologies in 
radiation oncology" at the 
United International Cancer 
Congress, Rio de Janeiro, 
Brazil, August 23. 
Weili Lin, PhD, assistant 
professor of radiology, spoke 
on "Cerebral oxygen satura- 
tion measurement using 
MRI" at the Xth International 
Workshop on MRA, Park 
City, Utah, September 30 - 
October 3. 
Jacob Locke, MD, assistant 
in radiology, presented "Risk 
factors for urinary retention 
in prostate brachytherapy 
patients" at the Western 
American Urological Associ- 
ation Annual Meeting, 
Hawaii, October 25. 
Daniel Low, PhD, assistant 
professor of radiology, pre- 
sented "Serial tomotherapy" 
at Stanford University and at 
the University of California, 
San Francisco, October 8 
and 9. 
Robert McKinstry, MD, 
PhD, instructor in radiology, 
as an invited speaker for a 
series of workshops spon- 
sored by the American Med- 
ical Association, presented 
"Physicians accessing the 
Internet" to the California 
Medical Association Leader- 
ship Council, Palm Springs, 
September 11; to the 
Alameda Contra Costa Med- 
ical Association, Oakland, 
California, October 17; to the 
1st Marine Expeditionary 
Force, Camp Pendleton, San 
Diego, California, November 
13; and at the American Med- 
ical Association House of 
Delegates meeting, 
Waikaloa, Hawaii, December 
10 -13. 
Jeff Michalski, MD, assis- 
tant professor of radiology, 
spoke on "Quality assurance 
in 3D RTP radiation therapy 
planning clinical trials" at the 
University of North Carolina, 
Chapel Hill, September 1. He 
presented "The challenge of 
delivering and verifying qual- 
ity conformal radiotherapy" 
at EPI, Phoenix, Arizona, 
October 29. Michalski spoke 
on "3D RT planning for 
CNS/pediatric tumors," 
"Quality assurance for 3D 
conformal radiation therapy 
trials," and "Treatment of 
prostate cancer: 3D confor- 
mal RT & BT," Haifa, Israel, 
November 17 and 18. 
Eduardo Moros, PhD, 
assistant professor of radiol- 
ogy, presented "Model for 
ultrasonic heating of chest- 
wall recurrences" at the Sym- 
posium on Modeling of Heat 
Transfer in Biological Sys- 
tems, International Mechani- 
cal Engineering Congress 
and Exposition, Anaheim, 
California, November 15 - 20. 
Vamsidhar Narra, MD, 
instructor in radiology, spoke 
on "MR imaging of the liver" 
at the Nizam's Institute of 
Medical Sciences, Hyder- 
abad, India, August 24. He 
presented "MR imaging of 
the pelvis" to the Indian Radi- 
ological and Imaging Associ- 
ation, Hyderabad, India, 
August 26. 
Carlos Perez, MD, profes- 
sor of radiology and director 
of the Radiation Oncology 
Center, spoke on "Cervix: 
management of stage I 
through mB" and "Hypoxic 
cell sensitizers/protectors" at 
the 17th UICC International 
Cancer Congress, Rio de 
Janeiro, Brazil, August 24 - 
28. He presented "Radiother- 
apy in the management of 
carcinoma of the prostate" 
and "Role of postoperative 
irradiation in T3 tumors and 
in patients with extensive 
axillary involvement" to the 
Third Turkish National 
Oncology Congress, Istanbul, 
Turkey, October 11-17. He 
spoke on "When is it appro- 
priate to treat breast cancer 
with irradiation alone: When 
is axillary nodal dissection 
not needed?" at the St. Louis 
Medical Society meeting, St. 
Louis, Missouri, November 
10. Perez presented "3-D con- 
formal radiation therapy in 
carcinoma of the prostate" at 
the 3-D Conformal External 
Radiation Therapy Confer- 
ence, Barcelona, Spain, 
November 24 - 26. Perez pre- 
sented "Conventional radia- 
tion therapy and neoadjuvant 
hormone therapy in localized 
carcinoma of the prostate" 
and "Three-dimensional con- 
formal radiation therapy and 
potential for intensity modu- 
lated radiation therapy" to 
the Italian Association of 
Radiation Oncology, Milan, 
Italy, November 27. He 
spoke on "Primary treatment 
of nasopharyngeal cancer," 
"Radiotherapy in the multi- 
disciplinary treatment of 
locally advanced head and 
neck carcinomas," "Treat- 
ment of recurrent nasopha- 
ryngeal cancer," "Advances 
in radiotherapy," "Radiation 
alone or combined with 
chemotherapy in carcinomas 
of the nasopharynx," and 
"Cancer of the salivary 
glands" at the 1st World Con- 
gress on Head and Neck 
Oncology meeting, Madrid, 
Spain, December 1-3. He 
presented "From conven- 
tional to conformal radiother- 
apy" and "LDR-HDR 
brachytherapy: USA experi- 
ence" to the World Board 
Congress of Brachytherapy, 
Guayaquil, Ecuador, Decem- 
ber 14 -16. 
Marcus Raichle, MD, pro- 
fessor of radiology and of 
neurology and neurobiology 
and codirector of the Divi- 
sion of Radiological Sci- 
ences, spoke on 
"Conservation of conscious 
ness: notes towards an ima 
ing-based theory" at the 
Neuroscience Colloquium, 
sponsored by the Medical 
University of South Carolin 
Charleston, September 17, 
and at the Cognitive Neuro- 
science Talk, Washington 
University School of Medi- 
cine, St. Louis, Missouri, 
November 18. He presente 
"Images of mind" at the St. 
Louis Science Center, St. 
Louis, Missouri, September 
22. Raichle spoke on 
"Emerging images of mind" 
at the Whitehead Institute 
Symposium, Cambridge, 
lassa 
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Massachusetts, October 25 - 
I 27. He spoke on "Searching 
for images of the mind" at 
the Princeton University 
Public Lecture, Princeton, 
New Jersey, December 2. As 
a panel member, he spoke 
on "The neurobiological 
bases of functional neu- 
roimaging" at the American 
College of Neuropsy- 
chopharmacology, Las 
I Croabas, Puerto Rico, 
December 14 -18. 
Joseph Roti Roti, PhD, 
professor of radiology, asso- 
ciate director of the Radia- 
tion Oncology Center, and 
chief of cancer biology, 
spoke on "Effects of 
835.62MHz FMCW and 847.74 
MHz CDMA microwaves on 
mammalian cell proliferation 
in vitro" at the 5th Michael- 
son Research Conference, 
Essex, Montana, August 14 - 
17. As invited speaker, he 
presented "Interactions of RF 
fields with molecular 
processes that relate to 
stress and genotoxic 
processes" to the U.S. Army 
Medical Research Detach- 
ment, Walter Reed Army 
Institute of Research, Brooks 
Air Force Base, Texas, Octo- 
ber 1 and 2. As invited 
speaker, he presented "Ther- 
mal effects and oncogenesis" 
to the UAL Safety and Effects 
Panel, St. Louis, Missouri, 
November 21. 
Henry Royal, MD, profes- 
i sor of radiology and associ- 
ate director of the Division 
of Nuclear Medicine, spoke 
on "Myocardial perfusion 
imaging protocols: Which 
one when?" at the Strategies 
for Effective Myocardial Per- 
fusion Imaging in Managing 
Patients with Coronary 
Artery Disease Symposium, 
sponsored by Mallinckrodt 
Institute and Washington 
University, St. Louis, Mis- 
souri, September 19. He pre- 
sented "Effects of low level 
radiation" and "Practical 
radiation accident manage- 
ment" at the Bethesda Naval 
Medical Center, Bethesda, 
Maryland, October 20. 
Stuart Sagel, MD, profes- 
sor of radiology, chief of 
chest radiology, and codirec- 
tor of body computed 
tomography, spoke on "CT 
of the thorax: anatomic vari- 
ants and pitfalls" and "CT of 
the mediastinum" at the 8th 
Summer Practicum of the 
Society of Computed Body 
Tomography and Magnetic 
Resonance, Olympic Valley, 
California, August 2-6. He 
presented "CT of the peri- 
cardium," "Anatomic vari- 
ants and pitfalls in thoracic 
CT," "Helical CT in the tho- 
rax," "CT of focal lung 
lesions," "CT of the medi- 
astinum," and "CT angiogra- 
phy for pulmonary 
embolism" to the 20th Inter- 
national Congress of Radiol- 
ogy, New Delhi, India, 
September 19 - 23. 
Maria Schmidt, MD, 
instructor in radiology, pre- 
sented "Breast care and you" 
at a community lecture 
sponsored by Boone Hospi- 
tal Center in recognition of 
Breast Cancer Awareness 
Month, Columbia, Missouri, 
October 29. 
Vijay Sharma, PhD, 
research assistant professor 
of radiology, presented "Tar- 
geting plasmodium falci- 
parum candidate 
chloroquine-resistance pro- 
tein (CG2) with novel metal 
(III) complexes" at the 
American Chemical Society 
Annual Meeting, Boston, 
Massachusetts, August 23- 
27. 
Probstein lecture 
On September 18, Dr. Dattatreyudu Nori, chairman of the 
Department of Radiation Oncology at New York Hospital- 
Cornell Medical Center, presented the Norman K. Probstein 
Oncology Lecture. Dr. Nori (left) shown with Carlos Perez, 
MD, director of the MIR Radiation Oncology Center, spoke 
on "Brachytherapy in localized carcinoma of the prostate." 
Now in its 12th year, the Probstein Lecture is given annually 
in recognition of meritorious contributions to oncology. 
Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine and director of the 
Division of Nuclear Medi- 
cine, as symposium modera- 
tor, spoke on "Introduction 
and description of overall 
program objectives" at the 
Strategies for Effective 
Myocardial Perfusion Imag- 
ing in Managing Patients 
with Coronary Artery Dis- 
ease Symposium, sponsored 
by Mallinckrodt Institute 
and Washington University, 
St. Louis, Missouri, Septem- 
ber 19. As invited lecturer, 
he presented "The emerging 
role of PET in the manage- 
ment of patients with can- 
cer" at The Fifty-fifth Annual 
Carman Lecture, sponsored 
by the Greater St. Louis 
Society of Radiologists and 
the St. Louis Metropolitan 
Medical Society, St. Louis, 
Missouri, October 20. As 
invited lecturer, he pre- 
sented "Applications of PET 
in management of patients 
with cancer" at The 23rd 
Annual Memorial Lecture, 
sponsored by the medical 
and dental staffs of St. 
Anthony's Medical Center, 
St. Louis, Missouri, Novem- 
ber 10. 
Marilyn Siegel, MD, pro- 
fessor of radiology and of 
pediatrics, presented "Spiral 
CT of the pediatric chest and 
abdomen," "Imaging the 
pediatric kidney," and 
"CT/MR of the pediatric 
pelvis" to the Society of 
Computed Tomography and 
Magnetic Resonance Imag- 
ing, Squaw Creek, Califor- 
nia, August 2-4. She spoke 
on "Pediatric spiral CT and 
techniques," "Spiral CT of 
the pediatric liver," "Spiral 
CT of the pediatric retroperi- 
toneum," and "Spiral CT of 
the pediatric chest" at the 
Spiral/Helical CT 1998: 
National Symposium, New 
York City, New York, Sep- 
tember 18 - 20. As visiting 
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lecturer, Siegel presented 
"Ultrasonography/CT of the 
acute pediatric abdomen" at 
St. Bartholomew Hospital, 
London, England, October 1. 
As visiting professor, she 
spoke on "Gray-scale and 
Doppler imaging of the 
acute pediatric abdomen" at 
the Oregon Radiologic Soci- 
ety Meeting, Portland, Octo- 
ber 28. As visiting 
professor, Siegel presented 
"MR imaging of bone mar- 
row," "MR imaging of soft 
tissue masses," "Spiral CT of 
the pediatric airway and 
great vessels," and "Sonog- 
raphy of intracranial hemor- 
rhage and ischemia" at the 
Oregon Health Sciences Uni- 
versity, Portland, October 29 
and 30. 
Douglas Spitz, PhD, assis- 
tant professor of radiology, 
spoke on "Genomic instabil- 
ity and catalase gene ampli- 
fication induced by chronic 
exposure to metabolic 
oxidative stress" at the 
William Beaumont Research 
Institute Radiation Oncology 
Retreat, Royal Oak, Michi- 
gan, September 18 and 19. 
He presented "Glucose 
deprivation-induced oxida- 
tive stress" at the Oxygen 
Society Meeting, Washing- 
ton, DC, November 20. He 
spoke on "Glucose depriva- 
tion-induced oxidative 
stress in human tumor cells" 
at the Cleveland Clinic 
Department of Cell Biology 
Fall Seminar Series, Cleve- 
land, Ohio, December 11. 
Todd Wasserman, MD, pro- 
fessor of radiology, pre- 
sented "Protectors" at the 
Combined Radiation/Med- 
ical Oncology Conference, 
New York University Med- 
ical Center, New York City, 
New York, September 9. He 
presented "Ethyol: a new 
approach to reducing radia- 
tion-induced xerostomia" to 
the Society of Otorhino- 
laryngology and Head-Neck 
Nurses, 22nd Annual Con- 
gress, San Antonio, Texas, 
September 14. He spoke on 
"Radioprotectors," "The con- 
tribution of radiotherapy in 
the management of 
Hodgkin's disease," and 
"The contribution of radio- 
therapy in the management 
of non-Hodgkin's lym- 
phomas" at the Third 
National Radiation Oncology 
Congress, Turkish Radiation 
Oncology Society, Istanbul, 
Turkey, October 11-14. 
Wasserman presented 
"Radioprotectors" at the 
New Strategies on Radiation 
Oncology Symposium, 
Madrid, Spain, October 16. 
He presented "Head and 
neck cancer health services" 
and the "Symposium Wrap- 
up Session" at the Cancer 
Care Quality of Life and Out- 
comes Symposium, Chicago, 
Illinois, November 13 and 14. 
AMERICAN ASSOCIATION 
OF PHYSICISTS IN 
MEDICINE 
The 40th Annual Meeting 
San Antonio, Texas 
August 9 -13, 1998 
Daniel Low, PhD, cochair, 
scientific session, "Intensity 
modulated radiation therapy 
II." 
POSTER PRESENTATIONS 
James Dempsey, PhD; 
Daniel Low, PhD; Assen 
Kirov, PhD; Jeffrey 
Williamson, PhD, 
"Quantitative film dosimetry 
with scanning laser film 
digitizers." 
Robert Drzymala, PhD; 
Sasa Mutic, PhD; Eric 
Klein, MS, "A comparison 
of imaging techniques for 
stereotactic localization." 
William Harms, BS; Eric 
Klein, MS; James Purdy, 
PhD, "Initial angular diver- 
gence of electron beams 
from Varian Clinac C/D 
machines." 
Eric Klein, MS, "Technol- 
ogy assessment of multileaf 
collimation: a North Ameri- 
can users survey." 
Eric Klein, MS; William 
Harms, BS; Sasa Mutic, 
PhD; James Purdy, PhD, 
"Dynamic and physical 
wedge calculations with 
FOCUS using the Clarkson 
and FFT convolution 
algorithms." 
John Matthews, DSc; 
James Purdy, PhD, 
"Progress in real-time 3D 
dose planning." 
Eduardo Moros, PhD; 
Xiaobing Fan, research 
associate; William Straube, 
MS; Robert Myerson, PhD, 
MD, "Towards three dimen- 
sional power deposition con- 
trol in superficial 
thermoradiotherapy." 
Eric Klein, MS, "Side table 
transmission for ETR and 
exact treatment couches." 
Jeffrey Williamson, PhD; 
James Dempsey, PhD; 
Assen Kirov, PhD, "Plastic 




Jeffrey Williamson, PhD, 
"U.S. NRC regulatory change 
from am ACMUI member's 
perspective." 
REFRESHER COURSES 
Eric Klein, MS, "Multileai 
collimation: general descrip- < 
tion, systems and technology i 
assessment." 
Jeffrey Williamson, PhD     , 
"Introduction to AAPM Task   j 
Group 59 report: high dos - 
rate brachytherapy treat- 
ment delivery." 
SCIENTIFIC SESSIONS 
Jeffrey Williamson, Phi 
"Dosimetric modeling of t 
microselection high dose 
rate Ir-192 source by the 
multigroup discrete ordi- 
nates method." 
Assen Kirov, PhD; James 
Dempsey, PhD; Jeffrey 
Williamson, PhD, "New 
highly effective water equh 
alent plastic scintillator 
materials for radiation 
dosimetry." 
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laniel Low, PhD; Ramesh 
enkatesan, research asso- 
ciate; Sasa Mutic, MS; 
Mark Haacke, PhD; James 
Purdy, PhD, "Evaluation of 
BANG (TM) gel for intensity 
modulated dose distribution 
measurements." 
( Sasa Mutic, MS; Daniel 
Low, PhD, "Superficial 
doses from serial tomother- 
apy delivery." 
James Purdy, PhD; 
William Harms, BS; Wal- 
ter Bosch, DSc; Jeff 
Michalski, MD, "Update on 
quality assurance of multi- 
institutional 3D radiotherapy 
clinical trials." 




October 23 - 25, 1998 
William Reinus. MD, sym- 
posium course director. 
SCIENTIFIC SESSIONS 
Premsri Barton, MD, 
"Missed breast cancer." 
Kyongtae Bae, MD, PhD, 
"Basic principles of spiral CT 
and volumetric data display 
techniques." 
Harold Bennett, MD, PhD, 
"Imaging of RLQ pain," "MR 
of the pancreas," "CT of 
abdominal trauma." 
DeWitte Cross, MD, "Cere- 
bral atherosclerosis: angio- 
graphic assessment and 
comparison to MRA," "Cere- 
bral aneurysms: angio- 
graphic assessment." 
Colin Derdeyn, MD, 
"Carotid imaging." 
Robert Feiwell, MD, 
"Imaging of white matter 
diseases in adults." 
Andrew Fisher, MD, "Imag- 
ing of urolithiasis," "Thoracic 
trauma," "Fractures and their 
implications." 
Mokhtar Gado, MD, "Imag- 
ing epilepsy." 
Harvey Glazer, MD, "Pit- 
falls in the radiologic diag- 
nosis of bronchogenic 
carcinoma." 
Robert Gropler, MD, "Risk 
assessment in patients with 
CAD," "Added value of 
myocardial imaging in 
patients with CAD." 
Fernando Gutierrez, MD, 
"Imaging the trachea," "Vas- 
cular abnormalities of the 
mediastinum." 
Jay Heiken, MD, "CT eval 
uation of the acute nontrau- 
matized abdomen," "Imaging 
evaluation of small bowel 
obstruction." 
WiUiam Middleton, MD, 
"Ultrasound of advanced 
gallbladder disease," "Ultra- 
sound of the bile ducts." 
WiUiam Reinus, MD, "MRI 
of elbow and ankle." 
Douglas Robertson, MD, 
PhD, "CT of the foot and 
ankle." 
Stuart Sagel, MD, "Nonva- 
scular abnormalities of the 
mediastinum," "CT of the 
pleura." 
Farid Shafaie, MD, "Spinal 
MRI," "Imaging of the post- 
operative spine." 
Cary Siegel, MD, "CT/MRI 
of focal renal masses." 
Sharlene Teefey, MD, 
"Duplex color sonography of 
the liver." 
William Totty, MD, "MRI of 
marrow." 
Pamela Woodard, MD, 
"Spiral CT for the detection 
ofPE." 
THE AMERICAN SOCIETY 
FOR THERAPEUTIC RADI- 
OLOGY AND ONCOLOGY 
Phoenix, Arizona 
October 25 - 29, 1998 
Jeffrey Bradley, MD, 
ASTRO Research Fellow. 
David Diamond, MD, Resi- 
dent Clinical/Basic Science 
Award Winner. 
James Purdy, PhD, 
abstract reviewer. 
GENERAL SESSION OF SOCIETY 
FOR RADIATION ONCOLOGY 
ADMINISTRATORS 
Eric Klein, MS, "Multileaf 
collimation: results from the 
first AAPM assessment of 
technology subgroup." 
PANELS 
Eric Klein, MD, "Outcomes 
assessment of technology." 
James Purdy, PhD, "Con 
formal radiation approaches 
to the treatment of early 
prostate cancer: techniques, 
outcomes and pitfalls." 
POSTER SESSIONS 
Walter Bosch, PhD, "An 
integrated image/clinical 
database for outcome stud- 
ies in 3D conformal radiation 
therapy." 
Sasa Mutic, MS, "A reduc- 
tion in the AAPM TG-36 
reported peripheral dose dis- 
tributions with tertiary multi- 
leaf collimation." 
Robert Myerson, PhD, 
MD, "Five fractions of pre- 
operative radiotherapy for 
selected cases of rectal car- 
cinoma: long term tumor 
control and tolerance." 
Marie Taylor, MD, "The 
impact of regional lymphatic 
irradiation on treatment out- 
comes for Tl and T2 node 
positive breast cancer 
patients treated with conser- 
vation therapy." 
SCIENTIFIC SESSIONS 
Jeffrey Bradley, MD, "The 
use of concomitant radio- 
therapy and an attenuated 
herpes simplex-1 virus 
improves survival in mice 
with intracranial glioblas- 
toma multiforme tumors." 
David Diamond, MD, 
Redox factor-1 (ReF-1) medi- 
ates the activation of AP-1 in 
HeLa NIH 3T3 cells in 
response to heat." 
Mary Graham, MD, "Sur- 
vival and prognostic factors 
of non-small cell lung cancer 
(NSCLC) patients treated 
with definitive three-dimen- 
sional (3D) radiation 
therapy." 
Perry Grigsby, MD, "Radio- 
therapy with or without mis- 
onidazole for patients with 
stages IIIB and IVA carci- 
noma of the cervix: final 
results of RTOG 80-05." 
Daniel Low, PhD, "Abut- 
ment-region dose distribu- 
tion heterogeneities in serial 
tomotherapy." 
Jeff Michalski, MD, "Pre- 
liminary report of toxicity 
following 3D radiation ther- 
apy for prostate cancer on 
3DOG/RTOG 9406." 
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The 14th Annual Meeting 
St. Louis, Missouri 
November 6 - 8, 1998 
Andrei Laszlo, PhD; Dou- 
glas Spitz, PhD; Joseph 
Roti Roti, PhD, program 
committee. 
Kathy Bles, Carolyn Crow- 
ell, Carla Thurman, local 
arrangements committee. 
SYMPOSIUM I: STRUCTURE 
AND CONSEQUENCES OF DNA 
DAMAGE 
Yi Wang, graduate research 





Peng Zhang, MD; William 
Wright, BS; Joseph Roti 
Roti, PhD, "Post-irradiation 
DNA supercoiling and 
radiosensitivity in XRCC4 
transfected XR-l-CHO vari- 
ant cells." 
WORKSHOP I: POST- 
RADIATION RESPONSES AND 
CELL DEATH 
Fiorenza Ianzini, PhD; 
Michael Mackey, PhD, 
"Mitotic catastrophe induced 
by light ions: kinetics and 
magnitude. "Reduced induc- 
tion of mitotic castrophe in 
cells with functional p53 
exposed to ionizing radia- 
tions: implications for 
genomic instability." 
SYMPOSIUM II: MODIFICA- 
TIONS OF TISSUE RESPONSES 
TO RADIATION INJURY 
Fiorenza Ianzini, PhD, 
chairperson. 
WORKSHOP II: REDOX-MEDI- 
ATED SIGNAL TRANSDUCTION 
Douglas Spitz, PhD, chair- 
person. 
Lee Albee, medical research 
technician; Prabhat 
Goswami, PhD, "Characteri- 
zation of a redox sensitive 3' 
untranslated region ribonu- 
cleoprotein complex associ- 
ated with cell-cycle coupled 
topoisomerase II (mRNA) 
turnover." 
Douglas Spitz, PhD, "Meta- 
bolic oxidative stress- 
induced signal transduction." 
David Gius, MD; David 
Diamond, MD; Heather 
Curry, MD; Regina 
Clemens, lab assistant; Ana 
Botero, MD; Douglas 
Spitz, PhD, "Redox regula- 
tion of AP-1 DNA-binding in 
HeLa and NIH 3T3 cells in 
response to heat." 
SYMPOSIUM III: THE BIOLOGI- 
CAL EFFECTS OF RADIO- 
FREQUENCY RADIATION 
Isabelle Lagroye, PhD; 
Barbara Wettring, medical 
research technician; 
Eduardo Moros, PhD; 
William Straube, MS; 
Cheryl Hoff, surgical assis- 
tant; Joseph Roti Roti, 
PhD, "Investigation of DNA 
damage after in vitro and in 
vivo exposure to 2450 MHz 
microwaves." 
Robert Malyapa, MD, PhD; 
Eric Ahern, medical 
research technician; 
Eduardo Moros, PhD; 
William Straube,MS; 
Joseph Roti Roti, PhD, 
"Lack of neoplastic transfor- 
mation in C3H 10T1/2 ceUs 
following exposure to cellu- 
lar phone communication 
frequencies." 
Ryuji Higashikubo, PhD; 
Victoria Culbreth, scien- 
tific coordinator; Douglas 
Spitz, PhD; William 
Straube, MS; Eduardo 
Moros, PhD; Joseph Roti 
Roti, PhD, "Radiofrequency 
electromagnetic fields have 
no effect on the in vivo pro- 
liferation of 9L brain tumor." 
Michael Niehoff, research 
assistant; Joseph Roti Roti, 
PhD; Douglas Spitz, PhD; 
Ryuji Higashikubo, PhD; 
Eduardo Moros, PhD; Dor- 
rine Cushman, surgical 
assistant; Cheryl Hoff, sur- 
gical assistant, "The effect of 
chronic exposure to 835.62 
MHz FMCW or 847.74 MHz 
CDMA on the incidence of 
spontaneous brain and cen- 
tral nervous system tumors." 
William Wright, BS; 
Joseph Roti Roti, PhD, 
"Computer-assisted analysis 
of 2D gels." 
SYMPOSIUM IV: CELLULAR 
RESPONSES TO THERMAL 
STRESS 
Ming-Shun Chen, PhD; 
Andrei Laszlo, PhD; 
Joseph Roti Roti, PhD, 
"Identification and charac- 
terization of a new member 
of the Hsp40 family, the 
Hsc40, in human and mouse 
cells." 
Andrei Laszlo, PhD; Teri 
Davidson, medical research 
technician; Silvia Laszlo, 
lab assistant, "Effect of pro 
teasome inhibitors on the 
localization of Hsp/Hsc70 
during recovery from heat 
shock." 
Robert VanderWaal, PhD; 
Joseph Roti Roti, PhD, 
"Effects of hyperthermia on 
the abundance of specific 
proteins at the nuclear 
matrix during S-phase and 
the morphology of DNA 
replication." 
Mai Xu, MD, PhD; Prabhat 
Goswami, PhD; Joseph 
Roti Roti, PhD, "Increased 
expression of certain cell 
surface proteins in chronic 
heat-resistant cells." 
Heather Curry, MD; 
Regina Clemens, lab assis- 
tant; Ana Botero, MD; 
David Gius, MD, "Heating 
of HeLa cells prior to radia- 
tion inhibits radiation- 
induced activation of the 
NF-(B) DNA-binding 
complex." 
WORKSHOP III: UNIFIED 
(INTEGRATED?) STRESS 
RESPONSE(S) 
Andrei Laszlo, PhD, 
chairperson. 
Hsiu-san Lin, MD, PhD; 
Theodore D'Rosario, 
research lab technician, 
"Adaptation of tumor cells o 
a high normoxic environ- 
ment decreases their sensi 
tivity to adriamycin." 
Ming-Shun Chen, PhD; 
William Wright, BS; 
Andrei Laszlo, PhD; 
Joseph Roti Roti, PhD, 'V 
multi-stress inducible gene 
(MSI) encodes multiple pro 
teins (via alternative splic- 
ing) which share signiflcan- 
sequence similarity with a 
yeast cell-cycle checkpoint 
protein, Rad24." 
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Douglas Spitz, PhD; Lori 
Worley, medical research 
technician; Julia Sim, 
senior medical research 
technician; Lisa Ridnour, 
PhD, "Glucose deprivation- 
induced oxidative stress." 
RADIOLOGICAL SOCIETY 
OF NORTH AMERICA 
The 84th Scientific Assem- 
bly and Annual Meeting 
Chicago, Illinois 
November 29 - December 4, 
1998 
KEYNOTE ADDRESS 
William McAlister, MD, 
"New horizons in pediatric 
■adiology." 
INFORAD PRESENTATIONS 
James Blaine, DSc, "An 
approach to enterprise 
imaging." 
Richard Slone, MD, "JPEG 
and JPEG 2000: compres- 
sion for medical images." 
INFORAD EXHIBITS 
Gregory Reiker, MS; 
Richard Slone, MD; 
Pamela Woodard, MD; 
David Gierada, MD; Stu- 
art Sagel, MD; Gilbert 
Jost, MD; James Blaine, 
DSc, "Image processing 
strategies in picture archiv- 
ing and communication 
systems." 
Winner of the 1998 RSNA 
Certificate of Merit Award 
Richard Slone, MD; Bruce 
Whiting, PhD: Edward 
Muka, MSE, "Demonstra- 
tion of JPEG and JPEG 2000 
compression for medical 
images." 
SCIENTIFIC EXHIBITS 
Pamela Woodard, MD; 
Fernando Gutierrez, MD, 
"Metastic involvement of the 
heart and pericardium." 
Anil Khosla, MD, 
"Craniofacial and appendic- 
ular osteomas." 
Peter Shile, MD; Thomas 
Pilgram, PhD, "BI-RADS 
feature assessments in mam- 
mography and their relation- 
ship to diagnostic accuracy." 
Dmitriy Yablonskiy, PhD; 
David Gierada, MD, "High- 
speed dynamic MRI of lung 
ventilation with hyperpolar- 
ized 3He and EPI." 
REFRESHER COURSES 
Jeffrey Brown, MD, 
"Practical abdominal MR 
imaging." 
Michael Darcy, MD, 
"Embolization techniques: a 
'how-not-to' workshop." 
Louis Gilula, MD, "Imaging 
of ligaments, capsules, and 
tendons of wrist and hand;" 
"Imaging upper-extremity 
trauma with plain films, CT, 
and MR." 
Jay Heiken, MD, "The 
acute abdomen: CT 
evaluation." 
David Hovsepian, MD, 
"Hysterosalpingography and 
selective salpingography (a 
'how-to' workshop)." 
William Middleton, MD, 
"Musculoskeletal US 
('hands-on' workshop)," 
"Practical tips in US—small 
parts: other musculoskeletal 
US." 
Scott Mirowitz, MD, 
"Shoulder MR imaging: tech- 
niques and interpretation." 
David Rubin, MD, "Shoul- 
der injuries." 
Scott Lecture 
Michael Welch, PhD, professor of radiology and codirector of 
MIR's Division of Radiological Sciences, was invited lecturer 
for the Twenty-seventh Annual Wendell G. Scott Memorial 
Lecture on October 12. Dr. Welch spoke on "Contrast agents 
in imaging: current status and future prospects." 
Stuart Sagel, MD, "Digital 
chest radiography: techniques 
and clinical applications." 
Cary Siegel, MD, "Advances 
and controversies in CT and 
MR of the genitourinary 
tract." 
Marilyn Siegel, MD, "Pedi- 
atric spinal CT: challenges 
of childhood." 
William Totty, MD, "Wrist 
and hand injuries." 
Jeffrey Williamson, PhD, 
"Update course in 
brachytherapy physics— 
quality delivery accuracy: 
quality assurance of 
brachytherapy treatment 
delivery and planning 
devices." 
SCIENTIFIC SESSIONS 
David Hovsepian, MD; 
Gregorio Sicard, MD; 
Brent Allen, MD; Daniel 
Picus, MD; Eric Maiden, 
MD, "Adjunctive use of 
metallic stents during place- 
ment of bifurcated endopros- 
theses for abdominal aortic 
aneurysm repair." 
Leo Lawler, MD; Marilyn 
Siegel, MD, "Characterizing 
inspiratory and expiratory CT 
appearance of lung 
parenchyma in asymptomatic 
pediatric lung transplant 
recipients." 
Marilyn Siegel, MD, "MR 
diagnosis of anterior cruciate 
ligament tears in children." 
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Continued from page 27 
William Middleton, MD; 
Sharlene Teefey, MD; 
Christine Menias, MD; 
John Leahy, MD, "Follow- 
up of patients at low risk for 
hepatic malignancy and a 
characteristic hemangioma 
on ultrasound." 
Louis Gilula, MD; Sean 
Pierce, MD, "Characteris- 
tics of scapholunate liga- 
ment communicating defects 
in symptomatic and asymp- 
tomatic wrists." 
Elizabeth McFarland, MD; 
Vamsidhar Narra, MD; 
Dan Hirselj, BS; Glenn 
Foster, RT, "Evaluation of 
the dynamic velopharynx 
during speech production 
with magnetic resonance 
imaging." 
Elizabeth McFarland, MD; 
Bruce Whiting, PhD; 
Barry Brunsden; Casey 
Dellabarca, BS, "Spiral CT 
colography rippling artifact: 
influence of acquisition para- 
meters on 3D virtual 
endoscopy images using in 
vitro colon phantom." 
Demetri Papadatos, MD, 
"Pancreas divisum revisited: 
prevalence in acute and 
chronic pancreatitis on MR 
cholangiopancreatography 
(MRCp)." 
Douglas Robertson, MD, 
PhD; Jie Yuan, PhD, "Pro- 
viding radiographic outcome 
data to the surgeons." 
Douglas Robertson, MD, 
PhD; Paul Commean, BEE; 
Kirk Smith, BEng; Andrew 
Fisher, MD, "Bone density 
changes within lumbar inter- 
body fusion cages: Can CT 
assess interbody fusions?" 
David Rubin, MD, "MR 
imaging of subscapularis ten- 
don tears: prospective accu- 
racy and identification of 
associated findings to reduce 
diagnostic errors." 
Joshua Shimony, MD, 
PhD; Erbil Akbudak, PhD; 
Robert McKinstry, MD; 
Thomas Cull, PhD; 
Thomas Conturo, MD, 
PhD, "Quantitative diffusion 
anisotropy imaging: normal 
values, anatomical findings, 
and results in relapsing 
remitting multiple sclerosis." 
Joshua Shimony, MD, 
PhD; Erbil Akbudak, PhD; 
Abraham Snyder, MD, 
PhD; Thomas Conturo, 
MD, PhD, "Diffusion imag- 
ing of the cervical spinal 
cord." 
Richard Slone, MD; Dan 
Hendrickson, BS; Sanjeev 
Bhalla, MD; Andrew 
Fisher, MD; Scott Kalt- 
man, MD; Pamela 
Woodard, MD; David Gier- 
ada, MD; Thomas Pilgram, 
PhD; Edward Muka, MSE, 
"Visually lossless compres- 
sion of digital chest 
radiographs." 
Sharlene Teefey, MD; 
William Middleton, 
MD,"Accuracy of sonogra- 
phy for determining individ- 
ual tendon movement in 
patients with full thickness 
rotator cuff tears." 
Sharlene Teefey, MD; 
William Middleton, MD, 
"Can sonography differenti- 
ate acute from chronic rota- 
tor cuff tears?" 
Elizabeth McFarland, MD, 
"GI tract unraveling with 
curved cross-sections." 
Pamela Woodard, MD; Jie 
Zheng, PhD; Vamsidhar 
Narra, MD; Mark Haacke, 
PhD, "Coronary MR angiog- 
raphy with MS-345, an 
intravascular contrast 
agent." 
Pamela Woodard, MD; 
Fernando Gutierrez, MD; 
Marilyn Siegel, MD; Philip 
Ludbrook, MBBS, "Com- 
parison of HASTE and con- 
ventional spin echo MRI 
techniques for assessment of 
congenital heart disease." 
Dmitriy Yablonskiy, PhD; 
David Gierada, MD, "High- 
speed dynamic MRI of lung 
ventilation with hyperpolar- 
ized 3He and EPI." 
Yuming Yin, MD; Louis 
Gilula, MD, "An arthro- 
graphic method to deter- 
mine the precise size and 
site of scapholunate and 
lunotriquetral ligament com- 
municating defects." 
FOR THE RECORD 
On page 17 of the Summer 
1998 issue of Focal Spot 
magazine, the listing for Dr. 
Antoinette Cortese should 
have read: She completed a 
one-year internship at the 
University of Nevada Affili- 
ated Hospitals and a four- 
year diagnostic radiology 
residency at the University 
of Washington. 
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tute-of-the-art positron emission tomography (PET) system is up and running in the Institute's seventh-floor PET facility. Thv 
$1.8 million system, known as EXACT HR+ will be heavily utilized for clinical brain and whole body PET studies. Duffy Cutler, PhD, 
assistant professor of radiology, views some of the EXACT-produced images that have higher resolution and extended axial fields. 
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